Delivery Order SPE2DB24D1107-SPE2DB24FZFS6

Award Date 9/4/24
Potential Completion Date 9/5/24
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of medical products, specifically Potassium Chloride 10 MEQ/100 ML Solution. The contract, valued at $1,788.15, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract has a January 17, 2024 ultimate completion date and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,246.30 firm fixed-price delivery order is for the supply of 4562316212 - POTASSIUM CL 10% (20MEQ/15ML) CUP UD 15ML. The contract has an ultimate completion date of September 27, 2023. Amerisourcebergen maintains an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,667.92, is for the delivery of Potassium Chloride 10% (20 MEQ/15ML) UD 15ML, a medical product. The award is a Delivery Order under an existing Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which is valued at $999,999,999 and runs through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,066.40 firm fixed-price delivery order is for the supply of Potassium Chloride Extended Release 20 MEQ Tablets in 500-count bottles. The contract has an ultimate completion date of May 7, 2025 and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
This federal contract award, valued at $10,015.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DB22D3301|SPE2DB25FY4GX) for the supply of 4568142788 - POTASSIUM CL 10% (40 MEQ/30 ML) CUP UD 30 ML. The award has a firm fixed price pricing type and an ultimate completion date of May 6, 2025. Amerisourcebergen Drug Corp is the prime contractor, and the...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide a pharmaceutical product - Potassium Cl 10% (20meq/15ml) Cup UD 15ml. The $1,137.68 contract has a completion date of January 23, 2024 and was awarded on January 22, 2024. Amerisourcebergen Drug Corp is a For Profit Organization that provides pharmaceutical products and services to U.S. government agencies, primarily the Department...
This is a $1,668.94 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of potassium chloride, a medical product, with a period of performance ending on May 22, 2025. The contract is not set aside and represents an open competition award. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,525.52 delivery order is for the supply of Potassium Chloride Injection, a critical medical product used to treat potassium deficiency. The contract is a firm-fixed-price delivery order with a completion date of May 12, 2022. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,542.26, is for the delivery of 4566803855 - POTASSIUM CL 10 MEQ/100 ML SOL 100ML, a medical supply item. The contract has an ultimate completion date of December 30, 2024. The award was not designated with a set-aside requirement, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,294.26 Firm Fixed Price Delivery Order contract is for the supply of 4563216276 Potassium Cl ER 20 MEQ Tablets in 500-count packages. The contract has an ultimate completion date of January 3, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
  • SPE2DB24D1107
    Indefinite Delivery Contract
  • SPE2DB24D1107-SPE2DB24FZFS6
    Delivery Order

This federal contract award is for the delivery of Potassium Chloride 10% (20 MEQ/15ML) 473ML to the Defense Logistics Agency (DLA). The $1,456.34 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 4, 2024, with a completion date of September 5, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, and the Department of Justice Federal Bureau of Investigation, valued up to $750,000 through May 2024, for providing a wide range of pharmaceutical and medical supplies to support federal healthcare programs and facilities.

Generated 12/4/24, 9:02 AM